In a recent study using diabetic mice, deletion of dihydroceramide desaturase 1 (DEGS1), an enzyme critical to the formation of ceramide from dihydroceramide, resolved hepatic steatosis and insulin resistance [49]. This evidence concerns the gene DEGS1 and Insulin resistance.